Vascular remodelling in cardiovascular diseases: hypertension, oxidation, and inflammation

J Totoń-Żurańska, TP Mikolajczyk, B Saju… - Clinical …, 2024 - portlandpress.com
Optimal vascular structure and function are essential for maintaining the physiological
functions of the cardiovascular system. Vascular remodelling involves changes in vessel …

Alkaline phosphatase: a novel treatment target for cardiovascular disease in CKD

M Haarhaus, V Brandenburg… - Nature Reviews …, 2017 - nature.com
Cardiovascular disease is the main cause of early death in the settings of chronic kidney
disease (CKD), type 2 diabetes mellitus (T2DM), and ageing. Cardiovascular events can be …

Endothelium-derived relaxing factors and endothelial function: A systematic review

F Nappi, A Fiore, J Masiglat, T Cavuoti, M Romandini… - Biomedicines, 2022 - mdpi.com
Background: The endothelium plays a pivotal role in homeostatic mechanisms. It specifically
modulates vascular tone by releasing vasodilatory mediators, which act on the vascular …

An overview of the mechanisms in vascular calcification during chronic kidney disease

J Voelkl, D Cejka, I Alesutan - Current Opinion in Nephrology and …, 2019 - journals.lww.com
An overview of the mechanisms in vascular calcification duri... : Current Opinion in Nephrology
and Hypertension An overview of the mechanisms in vascular calcification during chronic kidney …

Characterization of circular RNAs in vascular smooth muscle cells with vascular calcification

J Ryu, DH Kwon, N Choe, S Shin, G Jeong… - … Therapy-Nucleic Acids, 2020 - cell.com
Circular RNAs (circRNAs) are generally formed by back splicing and are expressed in
various cells. Vascular calcification (VC), a common complication of chronic kidney disease …

Inhibition of arterial medial calcification and bone mineralization by extracellular nucleotides: The same functional effect mediated by different cellular mechanisms

JJ Patel, D Zhu, B Opdebeeck… - Journal of cellular …, 2018 - Wiley Online Library
Arterial medial calcification (AMC) is thought to share some outward similarities to skeletal
mineralization and has been associated with the transdifferentiation of vascular smooth …

Current knowledge on the nucleotide agonists for the P2Y2 receptor

P Xu, X Feng, H Luan, J Wang, R Ge, Z Li… - Bioorganic & Medicinal …, 2018 - Elsevier
Abstract P2Y receptors are G-protein-coupled receptors (GPCRs) for extracellular
nucleotides. There are eight mammalian P2Y receptor subtypes (P2Y1, P2Y2, P2Y4, P2Y6 …

Highly Selective and Potent Ectonucleotide Pyrophosphatase-1 (NPP1) Inhibitors Based on Uridine 5′-Pα,α-Dithiophosphate Analogues

V Zelikman, J Pelletier, L Simhaev, A Sela… - Journal of Medicinal …, 2018 - ACS Publications
Ectonucleotide pyrophosphatase/phosphodiesterase-1 (NPP1) hydrolyzes phosphodiester
bonds of nucleotides such as ATP, resulting mainly in the formation of AMP and …

Senescence in vascular smooth muscle cells and atherosclerosis

Y Zha, W Zhuang, Y Yang, Y Zhou, H Li… - Frontiers in …, 2022 - frontiersin.org
Vascular smooth muscle cells (VSMCs) are the primary cell type involved in the
atherosclerosis process; senescent VSMCs are observed in both aged vessels and …

Extracellular nucleotides regulate arterial calcification by activating both independent and dependent purinergic receptor Signaling pathways

B Opdebeeck, IR Orriss, E Neven, PC D'Haese… - International journal of …, 2020 - mdpi.com
Arterial calcification, the deposition of calcium-phosphate crystals in the extracellular matrix,
resembles physiological bone mineralization. It is well-known that extracellular nucleotides …